» Articles » PMID: 29156629

Reconstruction of Craniomaxillofacial Bone Defects Using Tissue-Engineering Strategies with Injectable and Non-Injectable Scaffolds

Overview
Date 2017 Nov 22
PMID 29156629
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Engineering craniofacial bone tissues is challenging due to their complex structures. Current standard autografts and allografts have many drawbacks for craniofacial bone tissue reconstruction; including donor site morbidity and the ability to reinstate the aesthetic characteristics of the host tissue. To overcome these problems; tissue engineering and regenerative medicine strategies have been developed as a potential way to reconstruct damaged bone tissue. Different types of new biomaterials; including natural polymers; synthetic polymers and bioceramics; have emerged to treat these damaged craniofacial bone tissues in the form of injectable and non-injectable scaffolds; which are examined in this review. Injectable scaffolds can be considered a better approach to craniofacial tissue engineering as they can be inserted with minimally invasive surgery; thus protecting the aesthetic characteristics. In this review; we also focus on recent research innovations with different types of stem-cell sources harvested from oral tissue and growth factors used to develop craniofacial bone tissue-engineering strategies.

Citing Articles

Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.

Lau C, Park S, Ethiraj L, Singh P, Raj G, Quek J Int J Mol Sci. 2024; 25(12).

PMID: 38928517 PMC: 11204188. DOI: 10.3390/ijms25126805.


Influence of physicochemical characteristics of calcium phosphate-based biomaterials in cranio-maxillofacial bone regeneration. A systematic literature review and meta-analysis of preclinical models.

Sadeghian Dehkord E, De Carvalho B, Ernst M, Albert A, Lambert F, Geris L Mater Today Bio. 2024; 26:101100.

PMID: 38854953 PMC: 11157282. DOI: 10.1016/j.mtbio.2024.101100.


CA1 Modulates the Osteogenic Differentiation of Dental Follicle Stem Cells by Activating the BMP Signaling Pathway In Vitro.

Zhao J, Ge Y, Xue L, Xu Y, Yue J, Li C Tissue Eng Regen Med. 2024; 21(6):855-865.

PMID: 38652220 PMC: 11286914. DOI: 10.1007/s13770-024-00642-4.


3D Printing Applications for Craniomaxillofacial Reconstruction: A Sweeping Review.

Slavin B, Ehlen Q, Costello 2nd J, Nayak V, Bonfante E, Benalcazar Jalkh E ACS Biomater Sci Eng. 2023; 9(12):6586-6609.

PMID: 37982644 PMC: 11229092. DOI: 10.1021/acsbiomaterials.3c01171.


In Vivo Evaluation of Collagen and Chitosan Scaffold, Associated or Not with Stem Cells, in Bone Repair.

da Cunha M, Maia F, Iatecola A, Massimino L, de Guzzi Plepis A, da Conceicao Amaro Martins V J Funct Biomater. 2023; 14(7).

PMID: 37504852 PMC: 10381363. DOI: 10.3390/jfb14070357.


References
1.
CORNELL C, Lane J, Chapman M, Merkow R, Seligson D, Henry S . Multicenter trial of Collagraft as bone graft substitute. J Orthop Trauma. 1991; 5(1):1-8. View

2.
Kammerer P, Scholz M, Baudisch M, Liese J, Wegner K, Frerich B . Guided Bone Regeneration Using Collagen Scaffolds, Growth Factors, and Periodontal Ligament Stem Cells for Treatment of Peri-Implant Bone Defects . Stem Cells Int. 2017; 2017:3548435. PMC: 5603746. DOI: 10.1155/2017/3548435. View

3.
Lee J, Pereira C, Ren X, Huang W, Bischoff D, Weisgerber D . Optimizing Collagen Scaffolds for Bone Engineering: Effects of Cross-linking and Mineral Content on Structural Contraction and Osteogenesis. J Craniofac Surg. 2015; 26(6):1992-6. PMC: 4871115. DOI: 10.1097/SCS.0000000000001918. View

4.
Kang S, Yang H, Seo S, Han D, Kim B . Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A. 2007; 85(3):747-56. DOI: 10.1002/jbm.a.31572. View

5.
Thein-Han W, Liu J, Xu H . Calcium phosphate cement with biofunctional agents and stem cell seeding for dental and craniofacial bone repair. Dent Mater. 2012; 28(10):1059-70. PMC: 3535491. DOI: 10.1016/j.dental.2012.06.009. View